Pharmacokinetic and Anti-inflammatory Effects of Sanguinarine Solid Lipid Nanoparticles
- 352 Downloads
The sanguinarine (SG) was studied for its pharmacokinetic and anti-inflammatory activities with prepared solid lipid nanoparticles (SLNs). The sanguinarine solid lipid nanoparticles (SG-SLNs) were prepared by film-ultrasonic dispersion method and the entrapment efficiency of SG was higher at 75.6 %. The drug release profile of SG was examined in pH 7.4 PBS and 85 % of the SG loaded in SLNs was gradually released during 24 h. We used mice endotoxin shock model which was induced by lipopolysaccharide (1 mg/kg) to examine the anti-inflammatory function of SG-SLNs. Healthy Kunming mice were administered orally with saline, SG (10 mg/kg), and SG-SLNs (10 mg/kg), respectively, at 12 and 1 h before lipopolysaccharide (LPS) injection. Mice were sacrificed at 1 and 6 h, respectively, and blood was collect through the venous sinus to access inflammatory mediators. Pharmacokinetic studies proved that the AUC0→24 and C max of SG-SLNs were significantly increased compared that of SG. SG-SLNs revealed significant anti-inflammatory effects through inhibition of LPS-induced tumor necrosis factor-alpha level, interleukin 6 level, and nitric oxide production in serum. Therefore, it can be concluded that SG-SLNs led to a better oral bioavailability.
KEY WORDSsanguinarine solid lipid nanoparticles bioavailability inflammation inflammatory mediators
This work was supported by a research grant from Xi’an Jiaotong University.
- 4.Walterová, D., J. Ulrichová, I. Valka, J. Vicar, C. Vavreckova, E. Taborska, and V. Simanek. 1994. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta universitatis palackianae olomucensis Facultatis Medicae 139: 7–16.Google Scholar
- 12.Zhang, X., S. Lu, J. Han, S. Sun, L. Wang, and Y. Li. 2011. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside. Die Pharmazie-An International Journal of Pharmaceutical Sciences 66: 404–407.Google Scholar
- 14.Riddick, T. 1968. Control of colloid stability through zeta potential: with a closing chapter on its relationship to cardiovascular disease. Wynnewood, PA: Zeta-Meter. Inc.Google Scholar
- 22.Stoclet, J.C., B. Muller, R. Andriantsitohaina, and A. Kleschyov. 1998. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry. Biokhimiya 63: 826.Google Scholar
- 23.Li, W., T. Fan, Y. Zhang, X. Niu, and W. Xing. 2012. Effect of Chelerythrine against endotoxic shock in mice and its modulation of inflammatory mediators in peritoneal macrophages through the modulation of mitogen-activated protein kinase (MAPK) pathway. Inflammation 35: 1814–1824.PubMedCrossRefGoogle Scholar